Meeting to be held in San Francisco on January 12 at 11 am hosted by H.C. Wainwright.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCRX:
- Pacira Biosciences: Exparel-Led Growth and Discounted Valuation Support Attractive Risk–Reward and Buy Rating
- Pacira: Maintaining Buy on Durable Non-Opioid Growth and Share Buybacks Despite Near-Term Revenue Softness
- Closing Bell Movers: AXT Inc. slips after cutting Q4 revenue guidance
- Pacira reports preliminary FY25 revenue $726.4M, consensus $730.22M
- DOMA intends to nominate three director candidates at Pacira annual meeting